Skip to main content

May 2019

Column

Editor's Page
05/15/2019
Many oncology practices have adopted clinical pathways over the last 5 years with varying degrees of success. These mixed results may stem from a lack of understanding or full commitment from practices in terms of...
Many oncology practices have adopted clinical pathways over the last 5 years with varying degrees of success. These mixed results may stem from a lack of understanding or full commitment from practices in terms of...
Many...
05/15/2019
Journal of Clinical Pathways
Clinical Pathways GPS
05/15/2019
Chimeric antigen receptor (CAR) T-cell therapy is a new form of cancer therapy that uses a patient’s own immune system to fight the disease. This type of cell therapy uses an individualized process to develop a...
Chimeric antigen receptor (CAR) T-cell therapy is a new form of cancer therapy that uses a patient’s own immune system to fight the disease. This type of cell therapy uses an individualized process to develop a...
...
05/15/2019
Journal of Clinical Pathways
Pharma Insights
05/15/2019
Dr Hennessey relates her past personal experience with cancer care delivery when her mother was receiving chemotherapy for lung cancer, where an issue with care access could have significantly altered her mother’s...
Dr Hennessey relates her past personal experience with cancer care delivery when her mother was receiving chemotherapy for lung cancer, where an issue with care access could have significantly altered her mother’s...
Dr...
05/15/2019
Journal of Clinical Pathways

Department

Pathways in Practice
05/15/2019
JCP Editors
In this series, we speak with cancer care practitioners about how pathways are being used in their practices, how they are being applied in a particular disease state, and what challenges remain for treatment...
In this series, we speak with cancer care practitioners about how pathways are being used in their practices, how they are being applied in a particular disease state, and what challenges remain for treatment...
In...
05/15/2019
Journal of Clinical Pathways

Tools and Resources

Tools for Transformation
05/15/2019
Gordon Kuntz is a health care consultant and strategic advisor with over 30 years’ experience in a multitude of health care settings, working with payers and providers, and in technology and strategy. He began his...
Gordon Kuntz is a health care consultant and strategic advisor with over 30 years’ experience in a multitude of health care settings, working with payers and providers, and in technology and strategy. He began his...
Gordon...
05/15/2019
Journal of Clinical Pathways

Feature

From the Field
05/15/2019
Abstract: It was hypothesized that by introducing more intense supportive care and enhanced nurse navigation in high-acuity curable cancer patients, we could achieve the same results noted in patients with advanced...
Abstract: It was hypothesized that by introducing more intense supportive care and enhanced nurse navigation in high-acuity curable cancer patients, we could achieve the same results noted in patients with advanced...
...
05/15/2019
Journal of Clinical Pathways
Perspectives
05/15/2019
Abstract: For health care organizations, clinical pathways have historically been important tools for translating medical evidence into practice and delivering high-quality, cost-conscious (ie, high-value) care....
Abstract: For health care organizations, clinical pathways have historically been important tools for translating medical evidence into practice and delivering high-quality, cost-conscious (ie, high-value) care....
...
05/15/2019
Journal of Clinical Pathways